Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Activity of TAS4464, a novel NEDD8 activating enzyme E1 inhibitor, against multiple myeloma via inactivation of nuclear factor κB pathways.

Muraoka H, Yoshimura C, Kawabata R, Tsuji S, Hashimoto A, Ochiiwa H, Nakagawa F, Fujioka Y, Matsuo K, Ohkubo S.

Cancer Sci. 2019 Dec;110(12):3802-3810. doi: 10.1111/cas.14209. Epub 2019 Oct 23.

2.

Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.

Takaesu Y, Watanabe K, Numata S, Iwata M, Kudo N, Oishi S, Takizawa T, Nemoto K, Yasuda Y, Tagata H, Tsuboi T, Tsujino N, Hashimoto N, Matsui Y, Hori H, Yamamori H, Sugiyama N, Suwa T, Kishimoto T, Hishimoto A, Usami M, Furihata R, Iwamoto K, Fujishiro H, Nakamura T, Mizuno K, Inagaki T, Katsumoto E, Tomita H, Ohi K, Muraoka H, Atake K, Iida H, Nagasawa T, Fujita J, Yamamura S, Onitsuka T, Murata A, Takayanagi Y, Noda H, Matsumura Y, Takezawa K, Iga JI, Ichihashi K, Ogasawara K, Yamada H, Inada K, Hashimoto R.

Psychiatry Clin Neurosci. 2019 Oct;73(10):642-648. doi: 10.1111/pcn.12911. Epub 2019 Aug 22.

3.

N-Methyl-N-Nitrosourea-Induced Photoreceptor Degeneration Is Inhibited by Nicotinamide via the Blockade of Upstream Events before the Phosphorylation of Signalling Proteins.

Sugano E, Tabata K, Takezawa T, Shiraiwa R, Muraoka H, Metoki T, Kudo A, Iwama Y, Nakazawa M, Tomita H.

Biomed Res Int. 2019 Apr 23;2019:3238719. doi: 10.1155/2019/3238719. eCollection 2019.

4.

TAS4464, A Highly Potent and Selective Inhibitor of NEDD8-Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models.

Yoshimura C, Muraoka H, Ochiiwa H, Tsuji S, Hashimoto A, Kazuno H, Nakagawa F, Komiya Y, Suzuki S, Takenaka T, Kumazaki M, Fujita N, Mizutani T, Ohkubo S.

Mol Cancer Ther. 2019 Jul;18(7):1205-1216. doi: 10.1158/1535-7163.MCT-18-0644. Epub 2019 May 15.

PMID:
31092565
5.

Role of Nampt-Sirt6 Axis in Renal Proximal Tubules in Extracellular Matrix Deposition in Diabetic Nephropathy.

Muraoka H, Hasegawa K, Sakamaki Y, Minakuchi H, Kawaguchi T, Yasuda I, Kanda T, Tokuyama H, Wakino S, Itoh H.

Cell Rep. 2019 Apr 2;27(1):199-212.e5. doi: 10.1016/j.celrep.2019.03.024.

6.

[A CASE OF BRONCHIAL ASTHMA ASSOCIATED WITH BRONCHIOLAR EOSINOPHILIA AND TREATED WITH MEPOLIZUMAB].

Oyama B, Tsuburai T, Komase Y, Nishida K, Tsuruoka H, Usuba A, Muraoka H, Hida N, Mineshita M.

Arerugi. 2019;68(2):101-106. doi: 10.15036/arerugi.68.101. Japanese.

PMID:
30867360
7.

Discovery of 3-Ethyl-4-(3-isopropyl-4-(4-(1-methyl-1 H-pyrazol-4-yl)-1 H-imidazol-1-yl)-1 H-pyrazolo[3,4- b]pyridin-1-yl)benzamide (TAS-116) as a Potent, Selective, and Orally Available HSP90 Inhibitor.

Uno T, Kawai Y, Yamashita S, Oshiumi H, Yoshimura C, Mizutani T, Suzuki T, Chong KT, Shigeno K, Ohkubo M, Kodama Y, Muraoka H, Funabashi K, Takahashi K, Ohkubo S, Kitade M.

J Med Chem. 2019 Jan 24;62(2):531-551. doi: 10.1021/acs.jmedchem.8b01085. Epub 2018 Dec 21.

PMID:
30525599
8.

Escitalopram attenuates fear stress-induced increase in amygdalar dopamine following methamphetamine-induced sensitisation: Implications of fine-tuning action of selective serotonin reuptake inhibitors on emotional processing.

Muraoka H, Oshibuchi H, Kawano M, Kawano T, Tsutsumi T, Yamada M, Ishigooka J, Nishimura K, Inada K.

Eur J Pharmacol. 2018 Sep 5;834:1-9. doi: 10.1016/j.ejphar.2018.06.033. Epub 2018 Jul 5.

PMID:
29981749
9.

Genesis, goals and achievements of Long-Term Ecological Research at the global scale: A critical review of ILTER and future directions.

Mirtl M, T Borer E, Djukic I, Forsius M, Haubold H, Hugo W, Jourdan J, Lindenmayer D, McDowell WH, Muraoka H, Orenstein DE, Pauw JC, Peterseil J, Shibata H, Wohner C, Yu X, Haase P.

Sci Total Environ. 2018 Jun 1;626:1439-1462. doi: 10.1016/j.scitotenv.2017.12.001. Epub 2018 Feb 19.

10.

Diazepam suppresses the stress-induced dopaminergic release in the amygdala of methamphetamine-sensitized rat.

Kawano T, Oshibuchi H, Kawano M, Muraoka H, Tsutsumi T, Yamada M, Ishigooka J, Nishimura K, Inada K.

Eur J Pharmacol. 2018 Aug 15;833:247-254. doi: 10.1016/j.ejphar.2018.05.048. Epub 2018 Jun 6.

PMID:
29885289
11.

High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection.

Umino H, Hasegawa K, Minakuchi H, Muraoka H, Kawaguchi T, Kanda T, Tokuyama H, Wakino S, Itoh H.

Sci Rep. 2018 May 1;8(1):6791. doi: 10.1038/s41598-018-25054-y.

12.

Pulmonary Perfusion Using Intrabronchial Capnography in Pulmonary Artery Stenosis.

Nishine H, Muraoka H, Inoue T, Miyazawa T, Mineshita M.

Respiration. 2018;95(6):465-468. doi: 10.1159/000487712. Epub 2018 Apr 20.

13.

Penile calciphylaxis in a patient on combined peritoneal dialysis and hemodialysis.

Kasai T, Washida N, Muraoka H, Fujii K, Uchiyama K, Shinozuka K, Morimoto K, Tokuyama H, Wakino S, Itoh H.

CEN Case Rep. 2018 Nov;7(2):204-207. doi: 10.1007/s13730-018-0327-0. Epub 2018 Mar 28.

14.

Perfluorocyclopentadienyl Radical Derivative as an Organocatalyst for Oxidative Coupling of Aryl- and Thienylmagnesium Compounds under Atmospheric Oxygen.

Korenaga T, Nitatori K, Muraoka H, Ogawa S, Shimada K.

J Org Chem. 2018 Apr 20;83(8):4835-4839. doi: 10.1021/acs.joc.8b00299. Epub 2018 Mar 29.

PMID:
29557173
15.

Current and future carbon budget at Takayama site, Japan, evaluated by a regional climate model and a process-based terrestrial ecosystem model.

Kuribayashi M, Noh NJ, Saitoh TM, Ito A, Wakazuki Y, Muraoka H.

Int J Biometeorol. 2017 Jun;61(6):989-1001. doi: 10.1007/s00484-016-1278-9. Epub 2016 Dec 6.

PMID:
27924399
16.

Characteristic Magnetic Resonance Imaging Findings in Rheumatoid Arthritis of the Temporomandibular Joint: Focus on Abnormal Bone Marrow Signal of the Mandibular Condyle, Pannus, and Lymph Node Swelling in the Parotid Glands.

Hirahara N, Kaneda T, Muraoka H, Fukuda T, Ito K, Kawashima Y.

J Oral Maxillofac Surg. 2017 Apr;75(4):735-741. doi: 10.1016/j.joms.2016.09.051. Epub 2016 Oct 7.

PMID:
27815104
17.

Parotid Lymphadenopathy Is Associated With Joint Effusion in Non-Neoplastic Temporomandibular Disorders.

Muraoka H, Kaneda T, Kawashima Y, Hirahara N, Fukuda T, Muramatsu T, Ito K.

J Oral Maxillofac Surg. 2017 Mar;75(3):491-497. doi: 10.1016/j.joms.2016.09.013. Epub 2016 Sep 17.

PMID:
27741415
18.

Dopamine dynamics during emotional cognitive processing: Implications of the specific actions of clozapine compared with haloperidol.

Kawano M, Oshibuchi H, Kawano T, Muraoka H, Tsutsumi T, Yamada M, Inada K, Ishigooka J.

Eur J Pharmacol. 2016 Jun 15;781:148-56. doi: 10.1016/j.ejphar.2016.04.013. Epub 2016 Apr 13.

PMID:
27085900
19.

Spatio-temporal variations in photosynthesis.

Terashima I, Tang Y, Muraoka H.

J Plant Res. 2016 May;129(3):295-8. doi: 10.1007/s10265-016-0814-3. No abstract available.

PMID:
27043147
20.

Communication from Tubular Epithelial Cells to Podocytes through Sirt1 and Nicotinic Acid Metabolism.

Hasegawa K, Wakino S, Sakamaki Y, Muraoka H, Umino H, Minakuchi H, Yoshifuji A, Naitoh M, Shinozuka K, Futatsugi K, Urai H, Kanda T, Tokuyama H, Hayashi K, Itoh H.

Curr Hypertens Rev. 2016;12(2):95-104. Review.

PMID:
26931474
21.

A Novel Technique for the Placement of Endobronchial Watanabe Spigots Into the Bronchus: Side-Grasping Method.

Kida H, Muraoka H, Inoue T, Mineshita M, Kurimoto N, Miyazawa T.

J Bronchology Interv Pulmonol. 2016 Jan;23(1):71-5. doi: 10.1097/LBR.0000000000000213.

PMID:
26705017
22.

Development and Application of a Multielectron-Accepting Organic Oxidant for the Catalytic Transition-Metal-Free Oxidative Homocoupling of Grignard Reagents in Air.

Korenaga T, Nitatori K, Muraoka H, Ogawa S, Shimada K.

Org Lett. 2015 Nov 6;17(21):5500-3. doi: 10.1021/acs.orglett.5b02887. Epub 2015 Oct 27.

PMID:
26503294
23.

Quality of Life and Influential Factors in Patients Implanted With a Left Ventricular Assist Device.

Kato NP, Okada I, Imamura T, Kagami Y, Endo M, Nitta D, Fujino T, Muraoka H, Minatsuki S, Maki H, Inaba T, Kinoshita O, Nawata K, Hatano M, Yao A, Kyo S, Ono M, Jaarsma T, Kinugawa K.

Circ J. 2015;79(10):2186-92. doi: 10.1253/circj.CJ-15-0502. Epub 2015 Aug 10.

24.

Secure Combination Therapy With Low-Dose Bosentan and Ambrisentan to Treat Portopulmonary Hypertension Minimizing Each Adverse Effect.

Muraoka H, Imamura T, Hatano M, Maki H, Yao A, Kinugawa K, Komuro I.

Int Heart J. 2015;56(4):471-3. doi: 10.1536/ihj.15-007. Epub 2015 Jun 18.

25.

Reverse Remodeling Achieved by Combination Therapy With High-Dose Beta Blocker and Cardiac Resynchronization.

Muraoka H, Imamura T, Kinugawa K.

Int Heart J. 2015;56(4):462-5. doi: 10.1536/ihj.15-003. Epub 2015 Jun 18.

26.

A case of interferon-α-induced pulmonary arterial hypertension after living donor liver transplantation.

Ko T, Hatano M, Nitta D, Muraoka H, Minatsuki S, Imamura T, Inaba T, Maki H, Yao A, Kinugawa K, Komuro I.

Heart Vessels. 2016 Jul;31(7):1206-8. doi: 10.1007/s00380-015-0701-1. Epub 2015 Jun 17.

PMID:
26081027
27.

Acylated cyanidin 3-sophoroside-5-glucoside in purple-violet flowers of Moricandia arvensis (Brassicaceae).

Tatsuzawa F, Kato K, Sato M, Ito S, Muraoka H, Takahata Y, Ogawa S.

Nat Prod Commun. 2015 Mar;10(3):457-9.

PMID:
25924529
28.

Intractable pneumothorax managed by talc pleurodesis and bronchial occlusion with spigots.

Ishida A, Kida H, Muraoka H, Nishine H, Mineshita M, Miyazawa T.

Respirol Case Rep. 2015 Mar;3(1):13-5. doi: 10.1002/rcr2.88. Epub 2014 Dec 24.

29.

Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension.

Fujino T, Yao A, Hatano M, Inaba T, Muraoka H, Minatsuki S, Imamura T, Maki H, Kinugawa K, Ono M, Nagai R, Komuro I.

Int Heart J. 2015;56(1):86-93. doi: 10.1536/ihj.14-183. Epub 2015 Jan 7.

30.

Platelet-derived growth factor receptor-tyrosine kinase inhibitor, imatinib, is effective for treating pulmonary hypertension induced by pulmonary tumor thrombotic microangiopathy.

Minatsuki S, Miura I, Yao A, Abe H, Muraoka H, Tanaka M, Imamura T, Inaba T, Maki H, Hatano M, Kinugawa K, Yao T, Fukayama M, Nagai R, Komuro I.

Int Heart J. 2015;56(2):245-8. doi: 10.1536/ihj.14-220. Epub 2015 Feb 23.

31.

Low blood pressure, low serum cholesterol and anemia predict early necessity of ventricular assist device implantation in patients with advanced heart failure at the time of referral from non-ventricular assist device institutes.

Fujino T, Kinugawa K, Hatano M, Imamura T, Muraoka H, Minatsuki S, Inaba T, Maki H, Kinoshita O, Nawata K, Yao A, Ono M, Komuro I.

Circ J. 2014;78(12):2882-9. Epub 2014 Oct 30.

32.

TAS-116, a highly selective inhibitor of heat shock protein 90α and β, demonstrates potent antitumor activity and minimal ocular toxicity in preclinical models.

Ohkubo S, Kodama Y, Muraoka H, Hitotsumachi H, Yoshimura C, Kitade M, Hashimoto A, Ito K, Gomori A, Takahashi K, Shibata Y, Kanoh A, Yonekura K.

Mol Cancer Ther. 2015 Jan;14(1):14-22. doi: 10.1158/1535-7163.MCT-14-0219. Epub 2014 Nov 21.

33.

Low Blood Pressure, Low Serum Cholesterol and Anemia Predict Early Necessity of Ventricular Assist Device Implantation in Patients With Advanced Heart Failure at the Time of Referral From Non-Ventricular Assist Device Institutes.

Fujino T, Kinugawa K, Hatano M, Imamura T, Muraoka H, Minatsuki S, Inaba T, Maki H, Kinoshita O, Nawata K, Yao A, Ono M, Komuro I.

Circ J. 2014 Oct 30. [Epub ahead of print]

34.

Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness.

Imamura T, Kinugawa K, Murasawa T, Kagami Y, Endo M, Muraoka H, Fujino T, Inaba T, Maki H, Hatano M, Kinoshita O, Nawata K, Kyo S, Komuro I, Ono M.

Int Heart J. 2014;55(2):178-80. Epub 2014 Mar 14.

35.
36.

Forest biomass carbon sinks in East Asia, with special reference to the relative contributions of forest expansion and forest growth.

Fang J, Guo Z, Hu H, Kato T, Muraoka H, Son Y.

Glob Chang Biol. 2014 Jun;20(6):2019-30. doi: 10.1111/gcb.12512. Epub 2014 Jan 27.

PMID:
24464906
37.

Late-onset right ventricular failure in patients with preoperative small left ventricle after implantation of continuous flow left ventricular assist device.

Imamura T, Kinugawa K, Kato N, Muraoka H, Fujino T, Inaba T, Maki H, Kinoshita O, Hatano M, Kyo S, Ono M.

Circ J. 2014;78(3):625-33. Epub 2014 Jan 16.

38.

Cardiac compression by massive mediastinal haematoma due to bleeding from the ectopic bronchial artery.

Muraoka H, Higashikuni Y, Ando J, Komuro I.

Eur Heart J. 2014 Jun 14;35(23):1567. doi: 10.1093/eurheartj/eht520. Epub 2013 Dec 18. No abstract available.

PMID:
24357504
39.

Preoperative beta-blocker treatment is a key for deciding left ventricular assist device implantation strategy as a bridge to recovery.

Imamura T, Kinugawa K, Hatano M, Fujino T, Muraoka H, Inaba T, Maki H, Kagami Y, Endo M, Kinoshita O, Nawata K, Kyo S, Ono M.

J Artif Organs. 2014 Mar;17(1):23-32. doi: 10.1007/s10047-013-0748-7. Epub 2013 Dec 15.

PMID:
24337665
40.

Tolvaptan can improve clinical course in responders.

Imamura T, Kinugawa K, Minatsuki S, Muraoka H, Kato N, Inaba T, Maki H, Hatano M, Yao A, Komuro I.

Int Heart J. 2013;54(6):377-81.

41.

Immunoglobulin G4-related multiple systemic aneurysms and splenic aneurysm rupture during steroid therapy.

Tajima M, Hiroi Y, Takazawa Y, Muraoka H, Iwata H, Yamashita H, Hirata Y, Nagai R.

Hum Pathol. 2014 Jan;45(1):175-9. doi: 10.1016/j.humpath.2013.07.035. Epub 2013 Oct 15.

PMID:
24139216
42.

The protein Ocular albinism 1 is the orphan GPCR GPR143 and mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii.

Hiroshima Y, Miyamoto H, Nakamura F, Masukawa D, Yamamoto T, Muraoka H, Kamiya M, Yamashita N, Suzuki T, Matsuzaki S, Endo I, Goshima Y.

Br J Pharmacol. 2014 Jan;171(2):403-14. doi: 10.1111/bph.12459.

43.

Successful treatment of hemodynamic compromise caused by antibody-mediated and cellular rejection in a recipient 12 years after heart transplantation.

Imamura T, Kinugawa K, Kato N, Kagami Y, Endo M, Kaneko N, Minatsuki S, Muraoka H, Inaba T, Maki H, Hatano M, Doi K, Yao A, Takazawa Y, Ono M, Kyo S, Komuro I.

Int Heart J. 2013;54(5):328-31.

44.

Everolimus-incorporated immunosuppressant strategy improves renal dysfunction while maintaining low rejection rates after heart transplantation in Japanese patients.

Imamura T, Kinugawa K, Ono M, Kagami Y, Endo M, Minatsuki S, Muraoka H, Kato N, Inaba T, Maki H, Hatano M, Yao A, Kyo S, Komuro I.

Int Heart J. 2013;54(4):222-7.

45.

Experimental warming studies on tree species and forest ecosystems: a literature review.

Chung H, Muraoka H, Nakamura M, Han S, Muller O, Son Y.

J Plant Res. 2013 Jul;126(4):447-60. doi: 10.1007/s10265-013-0565-3. Epub 2013 May 21. Review.

PMID:
23689840
46.

A case with recovery of response to tolvaptan associated with remission of acute kidney injury and increased urine osmolality.

Imamura T, Kinugawa K, Kato N, Minatsuki S, Muraoka H, Inaba T, Maki H, Shiga T, Hatano M, Hosoya Y, Takahashi M, Yao A, Kyo S, Ono M, Komuro I.

Int Heart J. 2013;54(2):115-8.

47.

Acute pulmonary vasoreactivity test with sildenafil or nitric monoxide before left ventricular assist device implantation.

Imamura T, Kinugawa K, Hatano M, Kato N, Minatsuki S, Muraoka H, Inaba T, Maki H, Kimura M, Kinoshita O, Shiga T, Yao A, Kyo S, Ono M, Komuro I.

J Artif Organs. 2013 Sep;16(3):389-92. doi: 10.1007/s10047-013-0706-4. Epub 2013 Apr 5.

PMID:
23559349
48.

Accurate measurement of optical properties of narrow leaves and conifer needles with a typical integrating sphere and spectroradiometer.

Noda HM, Motohka T, Murakami K, Muraoka H, Nasahara KN.

Plant Cell Environ. 2013 Oct;36(10):1903-9. doi: 10.1111/pce.12100. Epub 2013 Apr 15.

49.

Successful conversion from thiazide to tolvaptan in a patient with stage d heart failure and chronic kidney disease before heart transplantation.

Imamura T, Kinugawa K, Kato N, Minatsuki S, Muraoka H, Inaba T, Maki H, Shiga T, Hatano M, Yao A, Kyo S, Ono M, Komuro I.

Int Heart J. 2013;54(1):48-50.

50.

Urine osmolality estimated using urine urea nitrogen, sodium and creatinine can effectively predict response to tolvaptan in decompensated heart failure patients.

Imamura T, Kinugawa K, Minatsuki S, Muraoka H, Kato N, Inaba T, Maki H, Shiga T, Hatano M, Yao A, Kyo S, Komuro I.

Circ J. 2013;77(5):1208-13. Epub 2013 Jan 12.

Supplemental Content

Loading ...
Support Center